Cragan JD, Gilboa SM: Including prenatal diagnoses in birth defects monitoring: experience of the Metropolitan Atlanta Congenital Defects Program. Birth Defects Res A Clin Mol Teratol 85(1):20, 2009
Cuckle H: Biochemical screening for Down syndrome. Eur J Obstet Gynecol Reprod Bioi 92(1):97, 2000
Cuckle H, Wald N, Stevenson JD, et al: Maternal serum alpha-fetoprotein screening for open neural tube defects in twin pregnancies. Prenat Diagn 10(2):71, 1990
Cuckle HS, Malone FD, Wright 0, et al: Contingent screening for Down syndrome-results from the FaSTER trial. Prenat Diagn 28(2):89, 2008
Curnow KJ, Wilkins-Haug L, Ryan A, et al: Detection of triploid, molar, and vanishing twin pregnancies by single-nucleotide polymorphism-based noninvasive prenatal test. Am J Obstet GynecoIo212(1):79.e1, 2015
Cutting GR: Modiier genetics: cystic ibrosis. Annu Rev Genomics Hum Genet 6:237, 2005
Cystic Fibrosis Mutation Database: CFMDB statistics. Available at: http:// www.genet.sickkids.on.ca/StatisticsPage.html. Accessed November 28, 2016
Dahdouh EM, Balayla J, Audibert F, et al: Technical update: preimplantation genetic diagnosis and screening. J Obstet Gynaecol Can 37(5):451, 2015
Dar P, Curnow KJ, Gross SJ, et al: Clinical experience and follow-up with large scale single nucleotide polymorphism-based noninvasive prenatal aneuploidy testing. Am J Obstet Gynecol 211(5):527.el, 2014
DasheJS: Aneuploidy screening in pregnancy. Obstet GynecoIo128(1):181, 2016
Dashe JS, Twickler OM, Santos-Ramos R, et al: Alpha-fetoprotein detection of neural tube defects and the impact of standard ultrasound. Am J Obstet GynecoIo195(6):1623,o2006
Davies SC, Cronin E, Gill M, et al: Screening for sickle cell disease and thalassemia: a systematic review with supplementary research. Heath Technol Assess 4(3):1,o2000
Davis e, Cuckle H, Yaron Y: Screening for Down syndrome-incidental diagnosis of other aneuploidies. Prenat Diagn 34(1o1): 1044, 2014 de Wert G, Liebaers I, Van De Velde H: The future (r)evolution of preimplantation genetic diagnosis/human leukocyte antigen testing: ethical reflections. Stem Cells 25(9):2167,o2007 de Wit Me, Srebniak MI, Govaerts LC, et al: Additional value of prenatal genomic array testing in fetuses with isolated structural ultrasound abnormalities and a normal karyorype: a systematic review of the literature. Ultrasound Obstet GynecoIo43(2):139, 2014
DiMaio MS, Baumgarten A, Greenstein RM, et al: Screening for fetal Down's syndrome in pregnancy by measuring maternal serum alpha-fetoprotein levels. N Engl J Med 317(6):342,o1987